Kunming Longjin Pharmaceutical Co., Ltd. (SHE:002750)

SHE:002750 Revenue

Kunming Longjin Pharmaceutical had revenue of 5.90M CNY in the quarter ending March 31, 2025, a decrease of -77.64%. This brings the company's revenue in the last twelve months to 45.99M, down -49.71% year-over-year. In the year 2024, Kunming Longjin Pharmaceutical had annual revenue of 66.48M, down -23.25%.

• Revenue (ttm): 45.99M
• Revenue Growth: -49.71%
• P/S Ratio: 5.14
• Revenue / Employee: 244.64K
• Employees: 188
• Market Cap: 236.30M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	66.48M	-20.14M	-23.25%
Dec 31, 2023	86.62M	-36.34M	-29.56%
Jan 1, 2023	122.97M	-579.55M	-82.50%
Jan 1, 2022	702.52M	448.49M	176.55%
Dec 31, 2020	254.03M	-21.27M	-7.72%